{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T07:03:12Z","timestamp":1762671792564},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2012,4,25]],"date-time":"2012-04-25T00:00:00Z","timestamp":1335312000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1007\/s12020-012-9674-3","type":"journal-article","created":{"date-parts":[[2012,4,24]],"date-time":"2012-04-24T11:03:27Z","timestamp":1335265407000},"page":"231-233","source":"Crossref","is-referenced-by-count":13,"title":["Glucose intolerance and primary hyperparathyroidism: an unresolved relationship"],"prefix":"10.1007","volume":"42","author":[{"given":"Mishaela R.","family":"Rubin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shonni J.","family":"Silverberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,4,25]]},"reference":[{"issue":"3","key":"9674_CR1","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1210\/jc.2004-1891","volume":"90","author":"MJ Bolland","year":"2005","unstructured":"M.J. Bolland, A.B. Grey, G.D. Gamble, I.R. Reid, Association between primary hyperparathyroidism and increased body weight: a meta-analysis. J. Clin. Endocrinol. Metab. 90(3), 1525\u20131530 (2005)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"9674_CR2","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1365-2265.1994.tb02442.x","volume":"40","author":"S Kumar","year":"1994","unstructured":"S. Kumar, A.O. Olukoga, C. Gordon, E.B. Mawer, M. France, J.P. Hosker, M. Davies, A.J. Boulton, Impaired glucose tolerance and insulin insensitivity in primary hyperparathyroidism. Clin Endocrinol (Oxf) 40(1), 47\u201353 (1994)","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"10","key":"9674_CR3","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1056\/NEJM197503062921003","volume":"292","author":"K Yasuda","year":"1975","unstructured":"K. Yasuda, Y. Hurukawa, M. Okuyama, M. Kikuchi, K. Yoshinaga, Glucose tolerance and insulin secretion in patients with parathyroid disorders. Effect of serum calcium on insulin release. N. Engl. J. Med. 292(10), 501\u2013504 (1975)","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"9674_CR4","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1046\/j.1464-5491.2002.00809.x","volume":"19","author":"M Procopio","year":"2002","unstructured":"M. Procopio, G. Magro, F. Cesario, A. Piovesan, A. Pia, N. Molineri, G. Borretta, The oral glucose tolerance test reveals a high frequency of both impaired glucose tolerance and undiagnosed Type 2 diabetes mellitus in primary hyperparathyroidism. Diabet. Med. 19(11), 958\u2013961 (2002)","journal-title":"Diabet. Med."},{"issue":"5","key":"9674_CR5","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1365-2362.1983.tb00116.x","volume":"13","author":"S Ljunghall","year":"1983","unstructured":"S. Ljunghall, M. Palmer, G. Akerstrom, L. Wide, Diabetes mellitus, glucose tolerance and insulin response to glucose in patients with primary hyperparathyroidism before and after parathyroidectomy. Eur. J. Clin. Invest. 13(5), 373\u2013377 (1983)","journal-title":"Eur. J. Clin. Invest."},{"issue":"3","key":"9674_CR6","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1046\/j.1365-2796.1998.00366.x","volume":"244","author":"S Valdemarsson","year":"1998","unstructured":"S. Valdemarsson, P. Lindblom, A. Bergenfelz, Metabolic abnormalities related to cardiovascular risk in primary hyperparathyroidism: effects of surgical treatment. J. Intern. Med. 244(3), 241\u2013249 (1998)","journal-title":"J. Intern. Med."},{"issue":"1","key":"9674_CR7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF02555816","volume":"46","author":"R Prager","year":"1990","unstructured":"R. Prager, G. Schernthaner, B. Niederle, R. Roka, Evaluation of glucose tolerance, insulin secretion, and insulin action in patients with primary hyperparathyroidism before and after surgery. Calcif. Tissue Int. 46(1), 1\u20134 (1990)","journal-title":"Calcif. Tissue Int."},{"issue":"4","key":"9674_CR8","doi-asserted-by":"crossref","first-page":"584","DOI":"10.4158\/EP10321.OR","volume":"17","author":"A Ishay","year":"2011","unstructured":"A. Ishay, P. Herer, R. Luboshitzky, Effects of successful parathyroidectomy on metabolic cardiovascular risk factors in patients with severe primary hyperparathyroidism. Endocr Pract 17(4), 584\u2013590 (2011)","journal-title":"Endocr Pract"},{"issue":"11","key":"9674_CR9","doi-asserted-by":"crossref","first-page":"4260","DOI":"10.1210\/jc.2005-2825","volume":"91","author":"S Ayturk","year":"2006","unstructured":"S. Ayturk, A. Gursoy, Tutuncu.N. Bascil, D.T. Ertugrul, N. Guvener Demirag, Changes in insulin sensitivity and glucose and bone metabolism over time in patients with asymptomatic primary hyperparathyroidism. J. Clin. Endocrinol. Metab. 91(11), 4260\u20134263 (2006)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"7","key":"9674_CR10","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1210\/jc.2008-2742","volume":"94","author":"J Bollerslev","year":"2009","unstructured":"J. Bollerslev, T. Rosen, C.L. Mollerup, J. Nordenstrom, M. Baranowski, C. Franco, Y. Pernow, G.A. Isaksen, K. Godang, T. Ueland, S. Jansson, Effect of surgery on cardiovascular risk factors in mild primary hyperparathyroidism. J. Clin. Endocrinol. Metab. 94(7), 2255\u20132261 (2009)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"11","key":"9674_CR11","doi-asserted-by":"crossref","first-page":"5348","DOI":"10.1210\/jc.2003-031014","volume":"88","author":"SJ Silverberg","year":"2003","unstructured":"S.J. Silverberg, J.P. Bilezikian, \u201cIncipient\u201d primary hyperparathyroidism: a \u201cforme fruste\u201d of an old disease. J. Clin. Endocrinol. Metab. 88(11), 5348\u20135352 (2003)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"9674_CR12","author":"I Cakir","year":"2012","unstructured":"I. Cakir, K. Unluhizarci, F. Tanriverdi, G. Elbuken, Z. Karaca, F. Kelestimur, Investigation of insulin resistance in patients with normocalcemic primary hyperparathyroidism. Endocrine (2012). doi: 10.1007\/s12020-012-9627-x","journal-title":"Endocrine"},{"issue":"5","key":"9674_CR13","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1530\/EJE-09-1067","volume":"162","author":"KM Tordjman","year":"2010","unstructured":"K.M. Tordjman, M. Yaron, E. Izkhakov, E. Osher, G. Shenkerman, Y. Marcus-Perlman, N. Stern, Cardiovascular risk factors and arterial rigidity are similar in asymptomatic normocalcemic and hypercalcemic primary hyperparathyroidism. Eur. J. Endocrinol. 162(5), 925\u2013933 (2010)","journal-title":"Eur. J. Endocrinol."},{"issue":"1","key":"9674_CR14","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1530\/eje.1.02173","volume":"155","author":"E Hagstrom","year":"2006","unstructured":"E. Hagstrom, E. Lundgren, J. Rastad, P. Hellman, Metabolic abnormalities in patients with normocalcemic hyperparathyroidism detected at a population-based screening. Eur. J. Endocrinol. 155(1), 33\u201339 (2006)","journal-title":"Eur. J. Endocrinol."},{"key":"9674_CR15","author":"E Grethen","year":"2012","unstructured":"E. Grethen, K.M. Hill, R. Jones, B.M. Cacucci, C.E. Gupta, A. Acton, R.V. Considine, M. Peacock, Serum leptin, parathyroid hormone, 1,25-dihydroxyvitamin D, fibroblast growth factor 23, Bone alkaline phosphatase, and sclerostin relationships in obesity. J. Clin. Endocrinol. Metab. (2012). doi: jc.2011-2280","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"8","key":"9674_CR16","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1210\/jc.2006-2802","volume":"92","author":"H Lowe","year":"2007","unstructured":"H. Lowe, D.J. McMahon, M.R. Rubin, J.P. Bilezikian, S.J. Silverberg, Normocalcemic primary hyperparathyroidism: further characterization of a new clinical phenotype. J. Clin. Endocrinol. Metab. 92(8), 3001\u20133005 (2007)","journal-title":"J. Clin. Endocrinol. Metab."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-012-9674-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12020-012-9674-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-012-9674-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T01:56:36Z","timestamp":1559440596000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12020-012-9674-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4,25]]},"references-count":16,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["9674"],"URL":"https:\/\/doi.org\/10.1007\/s12020-012-9674-3","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,4,25]]}}}